We handle the science and safety so you can focus on rediscovering your health and vitality
What ultimately may hold more promise for less well-resourced patients in either Medicaid or the program for the elderly and certain disabled groups, Medicare, are the agreements Novo Nordisk and Eli Lilly reached with the Trump administration on selling GLP-1 treatments for $245 a month to the public insurers
Beyond BED, bulimia nervosa (BN) also shares core features of impulsive, dysregulated eating and recurrent binge episodes, and GLP-1related satiety and reward pathways are likely relevant in both conditions [21]
This framework explains why some patients see dramatic improvements while others see modest changes
Less common but more serious side effects of GLP-1 agonists include: pancreatitis, an inflammation of the pancreas that causes abdominal pain gastroparesis, in which movement of food out of the stomach is slowed or stopped bowel obstruction, a blockage that keeps food from passing through the intestines gallstone attacks and bile duct blockage
Wan S, Sun H